Neuromodulator Units Are Not a Universal Currency: What the Numbers Actually Mean Across Brands

Walk into any consultation for wrinkle relaxing injections and you will hear the word unit within the first five minutes. Units are how neuromodulators are dosed, priced, and marketed. What is rarely explained is that a unit is not a fixed physical quantity like a milligram. It is a measure of biological activity, and every manufacturer defines it using its own proprietary assay. That single fact explains most of the confusion, and most of the misleading price comparisons, in this corner of aesthetic medicine.

What a unit actually measures. All of the injectable products in this category are built on botulinum toxin type A, a protein that blocks the release of acetylcholine at the junction between nerve and muscle. It does this by cleaving a protein called SNAP-25, which the nerve terminal needs in order to release its chemical signal. Less signal means less muscle contraction, which means the overlying skin creases less. A unit is defined by potency testing: historically, one unit corresponded to the dose lethal to fifty percent of a population of mice in a standardized assay, though manufacturers have increasingly moved to cell-based potency tests. The key point is that each company runs its own version of the test, with its own reference standards. There is no shared ruler.

The major players and their rough exchange rates. In the United States, five botulinum toxin type A products are approved for aesthetic use: onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA, prabotulinumtoxinA, and daxibotulinumtoxinA. OnabotulinumtoxinA, incobotulinumtoxinA, and prabotulinumtoxinA dose fairly similarly in clinical practice, often near a one to one relationship for the glabella, the frown lines between the brows. AbobotulinumtoxinA is the outlier that generates the most confusion. Its units are smaller in effect, and clinicians typically use somewhere between two and a half to three of its units for every one unit of onabotulinumtoxinA. So a treatment quoted as 50 units of one product and 20 units of another may represent essentially the same biological dose. DaxibotulinumtoxinA also uses its own unit scale and is typically dosed at 40 units in the glabella, a number that cannot be compared unit for unit to anything else.

Why price per unit is a trap. Some practices advertise a low per unit price for abobotulinumtoxinA next to a higher per unit price for onabotulinumtoxinA, and the arithmetic looks like a bargain until you remember the exchange rate. If one product requires roughly three times the units to achieve the same effect, a per unit price one third as high is not cheaper. It is the same. The more honest comparison is cost per treatment area, or cost per equivalent clinical outcome. Patients comparing quotes should ask two questions: which product, and how many units for this specific area. Only then do the numbers become comparable.

Formulation differences are real but often overstated. Beyond units, the products differ in what surrounds the active toxin. Some are packaged with accessory proteins, called complexing proteins, that the toxin naturally travels with. IncobotulinumtoxinA is purified to remove them. DaxibotulinumtoxinA replaces human albumin with a peptide excipient and carries clinical trial data suggesting a longer median duration, in the range of six months for the glabella versus the three to four months typical of the category. Whether complexing proteins matter for immune resistance over years of treatment remains debated, and true neutralizing antibody formation at cosmetic doses is uncommon with any modern product. Claims that one brand feels more natural than another are largely about dosing pattern and injector technique, not molecular identity: the active molecule cleaves the same target protein in every case.

Spread is about dilution and placement more than brand. A persistent belief holds that certain brands spread more and are therefore riskier for eyelid droop. Head to head studies suggest that diffusion is driven mostly by the volume of saline used to reconstitute the product and by injection depth and placement, with brand playing a smaller role than technique. A skilled injector using a concentrated dilution and precise placement can achieve a tight field of effect with any of the approved products.

The practical takeaway. Units are a within brand dosing language, not a cross brand one. When evaluating a quote or comparing past treatments, anchor on three things: the specific product, the total units used in each area, and the outcome and duration you experienced. If a new provider proposes a very different unit count, ask whether it reflects a different product, a different dilution, or a genuinely different dose. The chemistry is well understood. The arithmetic just needs translation.

Related reading: Building and toning muscle without surgery and Non-surgical treatments and darker skin tones: what to ask first.